RO.CH

257.8

+0.08%↑

NOVN.CH

96.41

+0.05%↑

LONN.CH

543.4

+0.59%↑

BANB.CH

67.25

+0.9%↑

RO.CH

257.8

+0.08%↑

NOVN.CH

96.41

+0.05%↑

LONN.CH

543.4

+0.59%↑

BANB.CH

67.25

+0.9%↑

RO.CH

257.8

+0.08%↑

NOVN.CH

96.41

+0.05%↑

LONN.CH

543.4

+0.59%↑

BANB.CH

67.25

+0.9%↑

RO.CH

257.8

+0.08%↑

NOVN.CH

96.41

+0.05%↑

LONN.CH

543.4

+0.59%↑

BANB.CH

67.25

+0.9%↑

RO.CH

257.8

+0.08%↑

NOVN.CH

96.41

+0.05%↑

LONN.CH

543.4

+0.59%↑

BANB.CH

67.25

+0.9%↑

Search

Sonova Holding AG

Open

BrancheGesundheitswesen

225.4 0.54

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

223.4

Max

226.1

Schlüsselkennzahlen

By Trading Economics

Einkommen

235M

443M

Verkäufe

199M

2B

KGV

Branchendurchschnitt

24.541

34.393

EPS

5.55

Dividendenrendite

1.98

Gewinnspanne

21.819

Angestellte

18,335

EBITDA

93M

510M

Empfehlungen

By TipRanks

Empfehlungen

Sell

12-Monats-Prognose

+13.69% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.98%

2.54%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.8B

13B

Vorheriger Eröffnungskurs

224.86

Vorheriger Schlusskurs

225.4

Nachrichtenstimmung

By Acuity

70%

30%

343 / 374 Ranking in Healthcare

Sonova Holding AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Sept. 2024, 10:08 UTC

Wichtige Markttreiber

Hearing Aid Stocks Drop After Apple Adds Health Features to AirPods

Peer-Vergleich

Kursveränderung

Sonova Holding AG Prognose

Kursziel

By TipRanks

13.69% Vorteil

12-Monats-Prognose

Durchschnitt 255.7 CHF  13.69%

Hoch 310 CHF

Tief 215 CHF

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sonova Holding AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

11 ratings

0

Buy

6

Halten

5

Sell

Stimmung

By Acuity

343 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.